Genetic effects on urinary 1-hydroxypyrene levels in a Korean population
Urinary 1-hydroxypyrene (1-OHP) has been used as a biomarker for assessing the level of exposure to environmental carcinogenic polycyclic aromatic hydrocarbons (PAHs). In order to perform the appropriate biological monitoring for examining the level of exposure to PAHs, this study investigated wheth...
Saved in:
| Published in | Carcinogenesis (New York) Vol. 24; no. 6; pp. 1085 - 1089 |
|---|---|
| Main Authors | , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Oxford
Oxford University Press
01.06.2003
Oxford Publishing Limited (England) |
| Subjects | |
| Online Access | Get full text |
| ISSN | 0143-3334 1460-2180 1460-2180 |
| DOI | 10.1093/carcin/bgg054 |
Cover
Loading…
| Abstract | Urinary 1-hydroxypyrene (1-OHP) has been used as a biomarker for assessing the level of exposure to environmental carcinogenic polycyclic aromatic hydrocarbons (PAHs). In order to perform the appropriate biological monitoring for examining the level of exposure to PAHs, this study investigated whether or not genetic polymorphisms of the metabolic enzymes, which might be involved in the metabolism of pyrene, affected the urinary 1-OHP levels in a population of 661 Koreans (male, 63%; female, 37%; mean age, 36.5 ± 11.1 years) who were not occupationally exposed to PAHs. Urinary 1-OHP was detected in 76% of the subjects (range 0.001–3.8 µg/l). Among the physical and lifestyle factors, cigarette-smoking was found to be associated with the urinary 1-OHP levels (P < 0.05). After adjusting for these factors, we found that the GSTT1 genotypes affected the urinary 1-OHP levels, i.e. the GSTT1 present subjects had ∼1.5 times the urinary 1-OHP level than the GSTT1 null subjects (P < 0.05). In the case of the subjects who were also GSTM1 null, this trend became stronger, i.e. the GSTT1 present subjects had ∼2 times the urinary 1-OHP level (P < 0.01). However, the genetic polymorphism of the other metabolic enzymes, cytochrome P-450 (CYP)1A1, CYP1B1 and GSTM1 alone, did not affect the urinary 1-OHP level. Therefore, this study suggests that the GSTT1 genetic polymorphism has the potential to affect the biological monitoring of PAHs with urinary 1-OHP, and might act as a genetic factor in PAH-related toxicity. |
|---|---|
| AbstractList | Urinary 1-hydroxypyrene (1-OHP) has been used as a biomarker for assessing the level of exposure to environmental carcinogenic polycyclic aromatic hydrocarbons (PAHs). In order to perform the appropriate biological monitoring for examining the level of exposure to PAHs, this study investigated whether or not genetic polymorphisms of the metabolic enzymes, which might be involved in the metabolism of pyrene, affected the urinary 1-OHP levels in a population of 661 Koreans (male, 63%; female, 37%; mean age, 36.5 +/- 11.1 years) who were not occupationally exposed to PAHs. Urinary 1-OHP was detected in 76% of the subjects (range 0.001-3.8 micro g/l). Among the physical and lifestyle factors, cigarette-smoking was found to be associated with the urinary 1-OHP levels (P < 0.05). After adjusting for these factors, we found that the GSTT1 genotypes affected the urinary 1-OHP levels, i.e. the GSTT1 present subjects had approximately 1.5 times the urinary 1-OHP level than the GSTT1 null subjects (P < 0.05). In the case of the subjects who were also GSTM1 null, this trend became stronger, i.e. the GSTT1 present subjects had approximately 2 times the urinary 1-OHP level (P < 0.01). However, the genetic polymorphism of the other metabolic enzymes, cytochrome P-450 (CYP)1A1, CYP1B1 and GSTM1 alone, did not affect the urinary 1-OHP level. Therefore, this study suggests that the GSTT1 genetic polymorphism has the potential to affect the biological monitoring of PAHs with urinary 1-OHP, and might act as a genetic factor in PAH-related toxicity. Urinary 1-hydroxypyrene (1-OHP) has been used as a biomarker for assessing the level of exposure to environmental carcinogenic polycyclic aromatic hydrocarbons (PAHs). In order to perform the appropriate biological monitoring for examining the level of exposure to PAHs, this study investigated whether or not genetic polymorphisms of the metabolic enzymes, which might be involved in the metabolism of pyrene, affected the urinary 1-OHP levels in a population of 661 Koreans (male, 63%; female, 37%; mean age, 36.5 + or - 11.1 years) who were not occupationally exposed to PAHs. Urinary 1-OHP was detected in 76% of the subjects (range 0.001-3.8 [mu]g/l). Among the physical and lifestyle factors, cigarette-smoking was found to be associated with the urinary 1-OHP levels (P < 0.05). After adjusting for these factors, we found that the GSTT1 genotypes affected the urinary 1-OHP levels, i.e. the GSTT1 present subjects had ~1.5 times the urinary 1-OHP level than the GSTT1 null subjects (P < 0.05). In the case of the subjects who were also GSTM1 null, this trend became stronger, i.e. the GSTT1 present subjects had ~2 times the urinary 1-OHP level (P < 0.01). However, the genetic polymorphism of the other metabolic enzymes, cytochrome P-450 (CYP)1A1, CYP1B1 and GSTM1 alone, did not affect the urinary 1-OHP level. Therefore, this study suggests that the GSTT1 genetic polymorphism has the potential to affect the biological monitoring of PAHs with urinary 1-OHP, and might act as a genetic factor in PAH-related toxicity. Urinary 1-hydroxypyrene (1-OHP) has been used as a biomarker for assessing the level of exposure to environmental carcinogenic polycyclic aromatic hydrocarbons (PAHs). In order to perform the appropriate biological monitoring for examining the level of exposure to PAHs, this study investigated whether or not genetic polymorphisms of the metabolic enzymes, which might be involved in the metabolism of pyrene, affected the urinary 1-OHP levels in a population of 661 Koreans (male, 63%; female, 37%; mean age, 36.5 +/- 11.1 years) who were not occupationally exposed to PAHs. Urinary 1-OHP was detected in 76% of the subjects (range 0.001-3.8 micro g/l). Among the physical and lifestyle factors, cigarette-smoking was found to be associated with the urinary 1-OHP levels (P < 0.05). After adjusting for these factors, we found that the GSTT1 genotypes affected the urinary 1-OHP levels, i.e. the GSTT1 present subjects had approximately 1.5 times the urinary 1-OHP level than the GSTT1 null subjects (P < 0.05). In the case of the subjects who were also GSTM1 null, this trend became stronger, i.e. the GSTT1 present subjects had approximately 2 times the urinary 1-OHP level (P < 0.01). However, the genetic polymorphism of the other metabolic enzymes, cytochrome P-450 (CYP)1A1, CYP1B1 and GSTM1 alone, did not affect the urinary 1-OHP level. Therefore, this study suggests that the GSTT1 genetic polymorphism has the potential to affect the biological monitoring of PAHs with urinary 1-OHP, and might act as a genetic factor in PAH-related toxicity.Urinary 1-hydroxypyrene (1-OHP) has been used as a biomarker for assessing the level of exposure to environmental carcinogenic polycyclic aromatic hydrocarbons (PAHs). In order to perform the appropriate biological monitoring for examining the level of exposure to PAHs, this study investigated whether or not genetic polymorphisms of the metabolic enzymes, which might be involved in the metabolism of pyrene, affected the urinary 1-OHP levels in a population of 661 Koreans (male, 63%; female, 37%; mean age, 36.5 +/- 11.1 years) who were not occupationally exposed to PAHs. Urinary 1-OHP was detected in 76% of the subjects (range 0.001-3.8 micro g/l). Among the physical and lifestyle factors, cigarette-smoking was found to be associated with the urinary 1-OHP levels (P < 0.05). After adjusting for these factors, we found that the GSTT1 genotypes affected the urinary 1-OHP levels, i.e. the GSTT1 present subjects had approximately 1.5 times the urinary 1-OHP level than the GSTT1 null subjects (P < 0.05). In the case of the subjects who were also GSTM1 null, this trend became stronger, i.e. the GSTT1 present subjects had approximately 2 times the urinary 1-OHP level (P < 0.01). However, the genetic polymorphism of the other metabolic enzymes, cytochrome P-450 (CYP)1A1, CYP1B1 and GSTM1 alone, did not affect the urinary 1-OHP level. Therefore, this study suggests that the GSTT1 genetic polymorphism has the potential to affect the biological monitoring of PAHs with urinary 1-OHP, and might act as a genetic factor in PAH-related toxicity. Urinary 1-hydroxypyrene (1-OHP) has been used as a biomarker for assessing the level of exposure to environmental carcinogenic polycyclic aromatic hydrocarbons (PAHs). In order to perform the appropriate biological monitoring for examining the level of exposure to PAHs, this study investigated whether or not genetic polymorphisms of the metabolic enzymes, which might be involved in the metabolism of pyrene, affected the urinary 1-OHP levels in a population of 661 Koreans (male, 63%; female, 37%; mean age, 36.5 ± 11.1 years) who were not occupationally exposed to PAHs. Urinary 1-OHP was detected in 76% of the subjects (range 0.001–3.8 µg/l). Among the physical and lifestyle factors, cigarette-smoking was found to be associated with the urinary 1-OHP levels (P < 0.05). After adjusting for these factors, we found that the GSTT1 genotypes affected the urinary 1-OHP levels, i.e. the GSTT1 present subjects had ∼1.5 times the urinary 1-OHP level than the GSTT1 null subjects (P < 0.05). In the case of the subjects who were also GSTM1 null, this trend became stronger, i.e. the GSTT1 present subjects had ∼2 times the urinary 1-OHP level (P < 0.01). However, the genetic polymorphism of the other metabolic enzymes, cytochrome P-450 (CYP)1A1, CYP1B1 and GSTM1 alone, did not affect the urinary 1-OHP level. Therefore, this study suggests that the GSTT1 genetic polymorphism has the potential to affect the biological monitoring of PAHs with urinary 1-OHP, and might act as a genetic factor in PAH-related toxicity. Urinary 1-hydroxypyrene (1-OHP) has been used as a biomarker for assessing the level of exposure to environmental carcinogenic polycyclic aromatic hydrocarbons (PAHs). In order to perform the appropriate biological monitoring for examining the level of exposure to PAHs, this study investigated whether or not genetic polymorphisms of the metabolic enzymes, which might be involved in the metabolism of pyrene, affected the urinary 1-OHP levels in a population of 661 Koreans (male, 63%; female, 37%; mean age, 36.5 plus or minus 11.1 years) who were not occupationally exposed to PAHs. Urinary 1-OHP was detected in 76% of the subjects (range 0.001-3.8 mu g/l). Among the physical and lifestyle factors, cigarette-smoking was found to be associated with the urinary 1-OHP levels (P < 0.05). After adjusting for these factors, we found that the GSTT1 genotypes affected the urinary 1-OHP levels, i.e. the GSTT1 present subjects had similar to 1.5 times the urinary 1-OHP level than the GSTT1 null subjects (P < 0.05). In the case of the subjects who were also GSTM1 null, this trend became stronger, i.e. the GSTT1 present subjects had similar to 2 times the urinary 1-OHP level (P < 0.01). However, the genetic polymorphism of the other metabolic enzymes, cytochrome P-450 (CYP)1A1, CYP1B1 and GSTM1 alone, did not affect the urinary 1-OHP level. Therefore, this study suggests that the GSTT1 genetic polymorphism has the potential to affect the biological monitoring of PAHs with urinary 1-OHP, and might act as a genetic factor in PAH-related toxicity. |
| Author | Yang, Mihi Lee, Eunil Kang, Daehee Jang, Jae-Yeon Cheong, Hae-Kwan Chang, Seong-Sil Lee, Su-Man Kim, Ho Kim, Soyeon Kawamoto, Toshihiro Shin, Hyoung Doo |
| Author_xml | – sequence: 1 givenname: Mihi surname: Yang fullname: Yang, Mihi organization: Department of Preventive Medicine/Cancer Research Institute, Seoul National University, Seoul, Korea – sequence: 2 givenname: Jae-Yeon surname: Jang fullname: Jang, Jae-Yeon organization: Department of Preventive Medicine and Public Health, Ajou University, Suwon, Korea – sequence: 3 givenname: Soyeon surname: Kim fullname: Kim, Soyeon organization: Department of Preventive Medicine and Public Health, Ajou University, Suwon, Korea – sequence: 4 givenname: Su-Man surname: Lee fullname: Lee, Su-Man organization: Department of Preventive Medicine/Cancer Research Institute, Seoul National University, Seoul, Korea – sequence: 5 givenname: Seong-Sil surname: Chang fullname: Chang, Seong-Sil organization: Department of Preventive Medicine and Public Health, Chungnam National University, Korea – sequence: 6 givenname: Hae-Kwan surname: Cheong fullname: Cheong, Hae-Kwan organization: Department of Preventive Medicine, College of Medicine, Dongguk University, Korea – sequence: 7 givenname: Eunil surname: Lee fullname: Lee, Eunil organization: Department of Preventive Medicine, Korea University, Seoul, Korea – sequence: 8 givenname: Daehee surname: Kang fullname: Kang, Daehee organization: Department of Preventive Medicine/Cancer Research Institute, Seoul National University, Seoul, Korea – sequence: 9 givenname: Ho surname: Kim fullname: Kim, Ho organization: School of Public Health, Seoul National University, Seoul, Korea – sequence: 10 givenname: Toshihiro surname: Kawamoto fullname: Kawamoto, Toshihiro organization: Department of Environmental Health, University of Occupational and Environmental Health, Kitakyushu, Japan – sequence: 11 givenname: Hyoung Doo surname: Shin fullname: Shin, Hyoung Doo organization: Department of Genetic Epidemiology, SNP Genetics, Seoul, Korea |
| BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=14925731$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/12807751$$D View this record in MEDLINE/PubMed |
| BookMark | eNqF0c9rFDEUB_AgFbutHr1KEPQ2Nj8nyVGKdqWLoigULyGTfamps8mYzEj3v3fWXS0UxFMun7zH-35P0FHKCRB6SskrSgw_8674mM6662sixQO0oKIlDaOaHKEFoYI3nHNxjE5qvSGEtlyaR-iYMk2UknSBlheQYIweQwjgx4pzwlOJyZUtps237brk2-2wLbPCPfyEvuKYsMOXuYBLeMjD1Lsx5vQYPQyur_Dk8J6iL2_ffD5fNqsPF-_OX68aLxkZG7lmUhunNDFAGddAXOiCB0FC6ySolinjdcsc0ZQB0GBYF2indHBCSiH4KXq5nzuU_GOCOtpNrB763iXIU7WKC6EN1f-FVGtKNNtNfH4P3uSppPkIy6jhUretmtGzA5q6DaztUOJmzsj-SXIGLw7AVe_6UFzysd45YZhUfOeavfMl11og3BFid43afaN23-js-T3v4_g78bG42P_z12FLrCPc_l3hync7H6OkXV59tR9XV5_ke3NpBf8FJii0lg |
| CODEN | CRNGDP |
| CitedBy_id | crossref_primary_10_1155_2014_801346 crossref_primary_10_5142_jgr_2011_35_3_339 crossref_primary_10_1002_em_20230 crossref_primary_10_1016_j_etap_2010_10_006 crossref_primary_10_1539_joh_49_183 crossref_primary_10_1081_GNC_200052205 crossref_primary_10_3109_03602532_2011_596204 crossref_primary_10_1002_em_10196 crossref_primary_10_1080_10590500701704037 crossref_primary_10_1016_j_fertnstert_2009_11_006 crossref_primary_10_1016_j_scitotenv_2007_02_021 crossref_primary_10_1016_j_mrfmmm_2005_06_009 crossref_primary_10_1158_1055_9965_EPI_05_0799 crossref_primary_10_1016_j_annepidem_2005_11_001 crossref_primary_10_1093_aje_kwi121 crossref_primary_10_1016_j_etap_2015_09_005 crossref_primary_10_1590_S1415_47572007000400002 crossref_primary_10_1158_1055_9965_1005_13_6 crossref_primary_10_7314_APJCP_2014_15_17_7105 |
| ContentType | Journal Article |
| Copyright | 2003 INIST-CNRS Copyright Oxford University Press(England) Jun 2003 |
| Copyright_xml | – notice: 2003 INIST-CNRS – notice: Copyright Oxford University Press(England) Jun 2003 |
| DBID | BSCLL AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 8FD FR3 P64 RC3 7X8 |
| DOI | 10.1093/carcin/bgg054 |
| DatabaseName | Istex CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Technology Research Database Engineering Research Database Biotechnology and BioEngineering Abstracts Genetics Abstracts MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Genetics Abstracts Engineering Research Database Technology Research Database Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic Genetics Abstracts |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1460-2180 |
| EndPage | 1089 |
| ExternalDocumentID | 351446131 12807751 14925731 10_1093_carcin_bgg054 ark_67375_HXZ_QLXR5N9K_4 |
| Genre | Research Support, Non-U.S. Gov't Journal Article |
| GeographicLocations | Asia Korea |
| GroupedDBID | --- -E4 .2P .55 .GJ .I3 .ZR 0R~ 18M 1TH 29B 2WC 3O- 4.4 482 48X 53G 5GY 5RE 5VS 5WA 5WD 6J9 70D A8Z AABZA AACZT AAIMJ AAJKP AAJQQ AAMDB AAMVS AAOGV AAPGJ AAPNW AAPQZ AAPXW AARHZ AAUAY AAUQX AAVAP AAVLN AAWDT ABDFA ABEFU ABEJV ABEUO ABGNP ABIME ABIXL ABJNI ABKDP ABLJU ABMNT ABNHQ ABNKS ABPIB ABPQP ABPTD ABQLI ABSMQ ABVGC ABWST ABXVV ABXZS ABZBJ ABZEO ACFRR ACGFO ACGFS ACNCT ACPQN ACPRK ACUFI ACUTJ ACUTO ACVCV ACZBC ADBBV ADEYI ADEZT ADFTL ADGKP ADGZP ADHKW ADHZD ADIPN ADMTO ADNBA ADOCK ADQBN ADRTK ADVEK ADYVW ADZTZ ADZXQ AEGPL AEGXH AEHUL AEJOX AEKPW AEKSI AELWJ AEMDU AENEX AENZO AEPUE AETBJ AEWNT AFFNX AFFQV AFFZL AFGWE AFIYH AFOFC AFRAH AFSHK AFYAG AGINJ AGKEF AGKRT AGMDO AGORE AGQPQ AGQXC AGSYK AHGBF AHMBA AHMMS AHXPO AIAGR AIJHB AJBYB AJDVS AJEEA AJNCP AKHUL AKWXX ALMA_UNASSIGNED_HOLDINGS ALUQC ALXQX ANFBD APIBT APJGH APWMN AQDSO AQKUS ARIXL ASAOO ASPBG ATDFG ATGXG ATTQO AVNTJ AVWKF AXUDD AYOIW AZFZN BAWUL BAYMD BCRHZ BEYMZ BHONS BQDIO BSCLL BSWAC BTRTY BVRKM BZKNY C1A C45 CAG CDBKE COF CS3 CXTWN CZ4 DAKXR DFGAJ DIK DILTD DU5 D~K E3Z EBD EBS EE~ EIHJH EJD ELUNK EMOBN F5P F9B FEDTE FHSFR FLUFQ FOEOM FOTVD FQBLK GAUVT GJXCC GX1 H13 H5~ HAR HVGLF HW0 HZ~ IH2 IOX J21 JXSIZ KAQDR KBUDW KOP KQ8 KSI KSN M-Z MBLQV MBTAY N9A NGC NLBLG NOMLY NOYVH NTWIH NU- NVLIB O0~ O9- OAWHX OBFPC OBOKY OCZFY ODMLO OJQWA OJZSN OK1 OPAEJ OVD OWPYF O~Y P2P PAFKI PB- PEELM PQQKQ Q1. Q5Y QBD R44 RD5 RIG RNI ROL ROX ROZ RUSNO RW1 RXO RZF RZO SV3 TCN TEORI TJX TLC TMA TR2 W8F WOQ X7H X7M XOL YAYTL YKOAZ YXANX ZGI ZKB ZKX ZXP ~91 AAYXX CITATION IQODW 6.Y ABNGD ABQTQ ABSAR ADJQC ADRIX AFXEN CGR CUY CVF ECM EIF FRP M49 NPM RHF 8FD FR3 P64 RC3 7X8 |
| ID | FETCH-LOGICAL-c520t-5d2589a7809e1238e0afbfce40f6a5e76279c862a0812ee1f92bf1b78fa455443 |
| ISSN | 0143-3334 1460-2180 |
| IngestDate | Fri Sep 05 12:24:46 EDT 2025 Thu Sep 04 22:09:10 EDT 2025 Mon Jun 30 12:14:09 EDT 2025 Wed Feb 19 01:33:53 EST 2025 Mon Jul 21 09:15:11 EDT 2025 Thu Apr 24 22:53:36 EDT 2025 Tue Jul 01 01:12:51 EDT 2025 Tue Aug 05 16:50:06 EDT 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 6 |
| Keywords | Human Urine Biological fluid Enzyme Toxicity Transferases Cytochrome P450 Rate Detoxification Biological marker Pyrene derivatives Genotype Polycyclic aromatic compound Carcinogen Glutathione transferase Risk factor Predisposition Molecular epidemiology Genetics Drug-metabolizing enzyme Polymorphism |
| Language | English |
| License | CC BY 4.0 |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c520t-5d2589a7809e1238e0afbfce40f6a5e76279c862a0812ee1f92bf1b78fa455443 |
| Notes | 9To whom correspondence should be addressed Email: jangjjy@madang.ajou.ac.kr ark:/67375/HXZ-QLXR5N9K-4 local:bgg054 istex:3EBEB84477A9414AE8DBD577DE29BA98CB2B1A0B ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Article-2 ObjectType-Feature-1 content type line 23 |
| OpenAccessLink | https://academic.oup.com/carcin/article-pdf/24/6/1085/7086260/bgg054.pdf |
| PMID | 12807751 |
| PQID | 219358667 |
| PQPubID | 5479 |
| PageCount | 5 |
| ParticipantIDs | proquest_miscellaneous_73448918 proquest_miscellaneous_18810824 proquest_journals_219358667 pubmed_primary_12807751 pascalfrancis_primary_14925731 crossref_primary_10_1093_carcin_bgg054 crossref_citationtrail_10_1093_carcin_bgg054 istex_primary_ark_67375_HXZ_QLXR5N9K_4 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2003-06-01 |
| PublicationDateYYYYMMDD | 2003-06-01 |
| PublicationDate_xml | – month: 06 year: 2003 text: 2003-06-01 day: 01 |
| PublicationDecade | 2000 |
| PublicationPlace | Oxford |
| PublicationPlace_xml | – name: Oxford – name: England |
| PublicationTitle | Carcinogenesis (New York) |
| PublicationTitleAlternate | Carcinogenesis |
| PublicationYear | 2003 |
| Publisher | Oxford University Press Oxford Publishing Limited (England) |
| Publisher_xml | – name: Oxford University Press – name: Oxford Publishing Limited (England) |
| SSID | ssj0016359 |
| Score | 1.8353653 |
| Snippet | Urinary 1-hydroxypyrene (1-OHP) has been used as a biomarker for assessing the level of exposure to environmental carcinogenic polycyclic aromatic hydrocarbons... |
| SourceID | proquest pubmed pascalfrancis crossref istex |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 1085 |
| SubjectTerms | 1-hydroxypyrene 1-OHP Adult Aryl Hydrocarbon Hydroxylases - genetics Biological and medical sciences BMI body mass index Codon Cytochrome P-450 CYP1A1 - genetics Cytochrome P-450 CYP1B1 Female geometric mean geometric standard deviation Glutathione Transferase - genetics GSD Humans Korea Male Medical sciences Middle Aged Multiple tumors. Solid tumors. Tumors in childhood (general aspects) PAHs polycyclic aromatic hydrocarbons Polymorphism, Genetic Pyrenes - metabolism Tumors |
| Title | Genetic effects on urinary 1-hydroxypyrene levels in a Korean population |
| URI | https://api.istex.fr/ark:/67375/HXZ-QLXR5N9K-4/fulltext.pdf https://www.ncbi.nlm.nih.gov/pubmed/12807751 https://www.proquest.com/docview/219358667 https://www.proquest.com/docview/18810824 https://www.proquest.com/docview/73448918 |
| Volume | 24 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELdgkxAvE9_rBsMPiJeSLV-O7Uc0ARVjk0CbFHixHNcpE1NStZ3E-Ou5i92kmVpp8BIlju183Pl8tn_-HSFvMh2BzyZYkJQmC9IiLoJCynEAnmtsyzLToWkAsmfZ6CL9nLN8GWjc7y5ZFIfmz9p9Jf8jVUgDueIu2X-QbFspJMA5yBeOIGE43knGyBmNhKstKKMa4uQ5AuGi4OfNGCEq0xskrRxeITiowb7q4Uk9w_n3aRu7a9VDPcbgQlU9QRt4Oe8H62knDb77WebTw96sQdKhm7yhS7MwgO7drYnYNWneOrodzl4LVk0dbltY6TbhUq41yY6uyjQvDyfFZBI62ug--fWtTqmFCrpF8kS5CpQrfp9sx5w3y_Kf8hbSA65lExyv_Q7PqQrFj1zxI1e854NsY3P6jZhYPYdmUbp4JpsHHI3jcf6I7PgRA33vxP-Y3LPVE_Lg1GMinpKR1wLqtYDWFfVaQG9pAXVaQC8rqqnTAtppwTNy8fHD-fEo8PExAsPicBGwccyE1FyE0oIDImyoy6I0Ng2hjTEL3RyXBkasGty-2NqolHFRRgUXpU4Z8h4-J1tVXdldQg0y0UXZGJxVkUoOXqwxSQnDA23ARMfRgLxb_jFlPHk8xjC5UmvlMyBv2-xTx5qyMWPz-9tcevYLoYacqVH-Q339kn9jZ_JEQcaDnny6apFdkyfwhvtLgSnfROcKuuOEiSzjA_K6vQv2ExfFdGXr67mKhADVjdPNOXiSpkJGYkBeOD3ono1UUpxFe3f93H3ysGuML8nWYnZtX4FTuygOGk3-CxEfoxM |
| linkProvider | Geneva Foundation for Medical Education and Research |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Genetic+effects+on+urinary+1-hydroxypyrene+levels+in+a+Korean+population&rft.jtitle=Carcinogenesis+%28New+York%29&rft.au=Yang%2C+M.&rft.date=2003-06-01&rft.issn=1460-2180&rft.eissn=1460-2180&rft.volume=24&rft.issue=6&rft.spage=1085&rft.epage=1089&rft_id=info:doi/10.1093%2Fcarcin%2Fbgg054&rft.externalDBID=n%2Fa&rft.externalDocID=10_1093_carcin_bgg054 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0143-3334&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0143-3334&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0143-3334&client=summon |